IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway
- 31 August 2011
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 55 (2), 289-298
- https://doi.org/10.1016/j.jhep.2010.11.019
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association StudyGastroenterology, 2010
- An overview about hepatitis C: A devastating virusCritical Reviews in Microbiology, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis CNature Genetics, 2009
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapyNature Genetics, 2009
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature, 2009
- A role for the host coatomer and KDEL receptor in early vaccinia biogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- Type III IFNs: New layers of complexity in innate antiviral immunityBioFactors, 2009
- Human interferon-λ3 is a potent member of the type III interferon familyGenes & Immunity, 2008
- Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cellsHepatology, 2008